Page last updated: 2024-09-03

tazobactam and albendazole

tazobactam has been researched along with albendazole in 2 studies

Compound Research Comparison

Studies
(tazobactam)
Trials
(tazobactam)
Recent Studies (post-2010)
(tazobactam)
Studies
(albendazole)
Trials
(albendazole)
Recent Studies (post-2010) (albendazole)
1,3271536944,9815392,033

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Barie, PS; Cayci, C; Eachempati, SR; Fusco, D; Goldstein, MJ; Huston, JM; Kapur, S; Mathew, M; Rodney, JR; Shou, J1

Other Studies

2 other study(ies) available for tazobactam and albendazole

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:3

    Topics: Aged, 80 and over; Albendazole; Animals; Anti-Infective Agents; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Ivermectin; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Protein C; Recombinant Proteins; Respiratory Distress Syndrome; Shock, Septic; Strongyloides stercoralis; Strongyloidiasis; Superinfection; Tazobactam; Treatment Outcome

2009